Cluster Headache Syndrome - Pipeline Review, H1 2017 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Cluster Headache Syndrome - Pipeline Review, H1 2017" report to their offering.

Cluster Headache Syndrome - Pipeline Review, H1 2017, provides an overview of the Cluster Headache Syndrome (Central Nervous System) pipeline landscape.

Cluster headache is pain that occurs along one side of the head. It is frequently occurs around, behind, or above the eye. Symptoms include burning, sharp, steady pain, red eye, runny nose, excessive tearing and flushed face. Risk factors include age and gender. Treatment includes anti-inflammatory (steroid) medicines and triptans.

The Cluster Headache Syndrome (Central Nervous System) pipeline guide reviews of key players involved in therapeutic development for Cluster Headache Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II and Phase I stages are 2, 2 and 2 respectively.

Cluster Headache Syndrome (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key Topics Covered:

  1. Introduction
  2. Cluster Headache Syndrome Overview
  3. Therapeutics Development
  4. Pipeline Products for Cluster Headache Syndrome - Overview
  5. Pipeline Products for Cluster Headache Syndrome - Comparative Analysis
  6. Cluster Headache Syndrome - Therapeutics under Development by Companies
  7. Cluster Headache Syndrome - Therapeutics under Investigation by Universities/Institutes
  8. Cluster Headache Syndrome Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Cluster Headache Syndrome - Products under Development by Companies
  13. Cluster Headache Syndrome - Products under Investigation by Universities/Institutes
  14. Cluster Headache Syndrome - Companies Involved in Therapeutics Development
  • Eli Lilly and Company
  • Entheogen Corp
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd
  • TrioxBio Inc

For more information about this report visit http://www.researchandmarkets.com/research/x57l5r/cluster_headache

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Analgesics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Analgesics